Drugs that cause shortness of breath
Pro Research Analysisby 
Searched over 200M research papers
Drugs That Cause Shortness of Breath
Shortness of breath, or dyspnea, can be a distressing side effect of various medications. Understanding which drugs can induce this symptom is crucial for healthcare providers to manage and mitigate risks effectively. This article synthesizes research findings on several drugs known to cause shortness of breath.
Clopidogrel and Shortness of Breath
Clopidogrel, an antiplatelet agent, has been reported to cause reversible shortness of breath in some patients. This side effect necessitates prompt recognition and management to prevent systemic complications .
Prednisone-Induced Dyspnea
Prednisone, a corticosteroid used for conditions like polymyalgia rheumatica, can induce episodes of shortness of breath. Although systematic evidence is limited, anecdotal reports and case studies confirm this side effect, suggesting potential mechanisms behind prednisone-induced dyspnea .
Mesalamine and Lung Toxicity
Mesalamine, a 5-aminosalicylate (5-ASA) drug used to treat ulcerative colitis, has been associated with lung toxicity. Patients may develop progressive shortness of breath, bilateral pulmonary infiltrates, and acute pneumonitis, indicating the need for careful monitoring of respiratory symptoms in patients on mesalamine .
Benzodiazepines and Respiratory Depression
Benzodiazepines, commonly prescribed for anxiety and insomnia, can adversely affect ventilation during sleep. These drugs may exacerbate sleep-related breathing disorders, particularly in patients with chronic obstructive pulmonary disease (COPD) or cardiac failure, leading to episodes of shortness of breath .
Levodopa and Parkinson’s Disease
Levodopa, a cornerstone treatment for Parkinson’s disease, can cause a "wearing-off" phenomenon, where the drug's effects diminish before the next dose. This can result in non-motor symptoms, including shortness of breath, which may be mistaken for other conditions like pulmonary or cardiac diseases .
Opioids and Breathlessness Management
Opioids are often used to manage breathlessness in palliative care settings. While they can effectively reduce dyspnea, their use must be carefully balanced to avoid respiratory depression. Short-acting opioids have shown efficacy in reducing breathlessness when administered before exertion or as needed for episodic dyspnea 59.
Conclusion
Several drugs, including clopidogrel, prednisone, mesalamine, benzodiazepines, and levodopa, have been linked to shortness of breath. Understanding these associations is vital for healthcare providers to manage and mitigate this distressing symptom effectively. Further research is needed to explore the mechanisms and develop guidelines for the safe use of these medications.
Sources and full results
Most relevant research papers on this topic